CYTOKINETICS INC — Director's Dealing 2019

Feb 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2019-01-31

Reporting Person: SCHLOSSBERG MARK A (SVP - Legal & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-31	Incentive Stock Option (right to buy)	$7.03	A	44756	Acquired	2029-01-31	Common Stock (44756)	Direct
2019-01-31	Non-Qualified Stock Option (right to buy)	$7.03	A	55244	Acquired	2029-01-31	Common Stock (55244)	Direct

Footnotes

F1: When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023.